Kestra Advisory Services, LLC Novo Cure LTD Transaction History

Kestra Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$75.08 - $121.99 $143,252 - $232,756	-1,908 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$116.17 - $194.55 $17,425 - $29,182	150 Added 8.53%	1,908 $221,000
Q2 2021 Jul 28, 2021	SELL	$130.4 - $225.58 $104,580 - $180,915	-802 Reduced 31.33%	1,758 $389,000
Q1 2021 May 10, 2021	SELL	$124.11 - $190.17 $49,768 - $76,258	-401 Reduced 13.54%	2,560 $338,000
Q4 2020 Jan 20, 2021	BUY	$112.16 - $174.14 $328,180 - $509,533	2,926 Added 8360.0%	2,961 $516 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $2,031 - $3,895	35 New	35 $290 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.